0001237899-11-000077.txt : 20111220 0001237899-11-000077.hdr.sgml : 20111220 20111220154426 ACCESSION NUMBER: 0001237899-11-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111216 FILED AS OF DATE: 20111220 DATE AS OF CHANGE: 20111220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 111272025 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2011-12-16 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001377247 Powchik Peter 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Clinical Development & Reg Incentive Stock Option (right to buy) 52.03 2011-12-16 4 A 0 1921 A 2021-12-16 Common Stock 1921 1921 D Non-Qualified Stock Option (right to buy) 16.8 2011-12-16 4 A 0 30000 A 2011-12-17 2018-12-17 Common Stock 30000 45000 D Non-Qualified Stock Option (right to buy) 52.03 2011-12-16 4 A 0 30079 A 2021-12-16 Common Stock 30079 30079 D The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. On December 17, 2008, the reporting person was granted an option to purchase 30,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2011, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2011. The performance criteria have been met and the option will vest as to all 30,000 shares on December 31, 2011. /s/**Peter Powchik 2011-12-20